Zentalis Pharmaceuticals, Inc.·4

Sep 1, 9:16 PM ET

Pinto Alexis 4

4 · Zentalis Pharmaceuticals, Inc. · Filed Sep 1, 2020

Insider Transaction Report

Form 4
Period: 2020-08-31
Pinto Alexis
Chief Legal Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-08-31+275,000275,000 total
    Exercise: $34.40Exp: 2030-08-30Common Stock (275,000 underlying)
Footnotes (1)
  • [F1]The options vest and become exercisable as to 25% of the total number of shares underlying the option on August 31, 2021 and as to the remaining 75% in 36 substantially equal monthly installments thereafter.

Documents

1 file
  • 4
    wf-form4_159900936053889.xmlPrimary

    FORM 4